International Clinical Trial: An Exploratory Phase 2 Study to Evaluate the Efficacy and Safety of SKI-O-703 (SYK Inhibitor) for the Prevention of Recurrence in Patients With Immune Thrombocytopenia (ITP) After Response to First-Line Standard Treatment

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (KCT0011512) titled 'An Exploratory Phase 2 Study to Evaluate the Efficacy and Safety of SKI-O-703 (SYK Inhibitor) for the Prevention of Recurrence in Patients With Immune Thrombocytopenia (ITP) After Response to First-Line Standard Treatment' on Jan. 21.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: The Catholic University of Korea, Seoul St. Mary's Hospital

Condition:

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Inter...